Yields go up, stocks go down. Again. Is this the new normal?

GSK eyes next-gen COVID vaccine as it inks deal to help boost current supply

Enlarge / A vaccine syringe and vial in front of the GSK (GlaxoSmithKline) logo. (credit: Getty | Anadolu Agency) After its own COVID-19 vaccine setback, GlaxoSmithKline has inked a $180 million deal to help German biotech CureVac manufacture 100 million doses of its mRNA vaccine, which is currently under development. The deal also lays the […]

Melinda French Gates’ Pivotal Ventures pours more money into female-focused venture fund

Her firm is joining Female Founders Fund’s latest $57 million fund. Read More

A.I. is helping detect cyberattacks. It needs to do more

Companies need to use A.I. to prevent and respond to cyberattacks. After all, hackers are using A.I. too. Read More